Neuroaid clinical trials
Also written MLC901 and MLC601.
How each study uses Neuroaid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Neuroaid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 7
Moleac Pte Ltd. (4) · Shahid Beheshti University of Medical Sciences (2) · National University Hospital, Singapore (2) · CHIMES Society (1) · Shahid Beheshti University (1) · EVD Pharmacy and Medical Company Limited (1) · University of the Philippines (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test Neuroaid.
- Sep 2027NeuroAiD Patient-Reported Outcomes in Patients With Mild to Moderate Ischemic StrokePhase 4 · EVD Pharmacy and Medical Company Limited
Studies
Open first, then newest update. How each study uses Neuroaid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 12
- NeuroAiD Patient-Reported Outcomes in Patients With Mild to Moderate Ischemic StrokeRecruitingPhase 4EVD Pharmacy and Medical Company LimitedNCT07828210Written as MLC901
- Alzheimer's Disease THErapy With NEuroaid IINot yet recruitingPhase 3Moleac Pte Ltd.NCT07191028Written as MLC 901
- MLC901 in Moderate Traumatic Brain InjuryRecruitingPhase 4University of the PhilippinesNCT04766281Written as MLC901
- Spinal Cord Injury - Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiDCompletedPhase 4Moleac Pte Ltd.NCT02537899Written as NeuroAiD
- NeuroAiD II™ (MLC901) in Mild Traumatic Brain InjuryCompletedPhase 3Moleac Pte Ltd.NCT04861688Written as Traditional Chinese Medicine (NeuroAiD II™ (MLC901)
- MLC901 in Hypoxic-ischemic Brain Injury Patients; A Double-blind, Randomized Placebo-controlled TrialCompletedEarly Phase 1Shahid Beheshti University of Medical SciencesNCT05621590Written as MLC 901
- NEURoaid II (MLC 901) Assessment in Cognitively Impaired Not Demented SubjectsCompletedPhase 2National University Hospital, SingaporeNCT01847924Written as MLC901
- The Alzheimer's Disease THErapy With NEuroaid (ATHENE) StudyStatus unknownPhase 2National University Hospital, SingaporeNCT03038035Written as MLC901
- CHInese Medicine NeuroAid Efficacy on Stroke RecoveryCompletedPhase 3CHIMES SocietyNCT00554723Written as NeuroAid
- Efficacy and Tolerability of MLC601 in Patients With Mild to Moderate Alzheimer Disease Who Were Unable to Tolerate or Failed to Benefit From Treatment With RivastigmineCompletedPhase 2Shahid Beheshti University of Medical SciencesNCT01696123Written as MLC601
- Clinical Study to Investigate the Safety and Efficacy of MLC601 in 150 Iranian Patients After StrokeCompletedPhase 4Shahid Beheshti UniversityNCT01336153Written as MLC601
- Study of NeuroAid In Enhancing Recovery After StrokeCompletedPhase 2Moleac Pte Ltd.NCT00721825Written as Neuroaid
Codes
What other systems call Neuroaid · ClinicalTrials.gg INT005557
- MeSH (NLM) C546417NeuroaidOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C546417 | Neuroaid | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.